missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Mouse ASAHL/N-acylethanolamine-hydrolyzing Acid A Antibody, R&D Systems™
Goat Polyclonal Antibody
Brand: R&D Systems AF4886
This item is not returnable.
View return policy
Description
ASAHL/N-acylethanolamine-hydrolyzing Acid Amidase Polyclonal specifically detects ASAHL/N-acylethanolamine-hydrolyzing Acid Amidase in Mouse samples. It is validated for Western Blot, Immunoprecipitation.
Specifications
| ASAHL/N-acylethanolamine-hydrolyzing Acid Amidase | |
| Polyclonal | |
| Unconjugated | |
| AAH04572 | |
| NAAA | |
| Mouse myeloma cell line NS0-derived recombinant mouse ASAHL/N-acylethanolamine-hydrolyzing Acid A Val33-Ser362 Accession # AAH04572 | |
| 100 μg | |
| Primary | |
| Detects mouse ASAHL/N-acylethanolamine-hydrolyzing Acid A in direct ELISAs and Western blots. In direct ELISAs, approximately 10% cross-reactivity with recombinant human (rh) ASAHL is observed and less than 5% cross-reactivity rhASAHL-2 and recombinant mouse ASAHL-2 is observed. | |
| Mouse | |
| IgG |
| Western Blot, Immunoprecipitation | |
| LYOPH | |
| Western Blot 1 ug/mL, Immunoprecipitation 25 ug/mL | |
| Acid ceramidase-like protein, ASAHL, ASAH-like protein, EC 3.5.1.-, NAAA, N-acylethanolamine acid amidase, N-acylethanolamine-hydrolyzing acid amidase, Nacylethanolaminehydrolyzing Acid Amidase, N-acylsphingosine amidohydrolase (acid ceramidase)-like, N-acylsphingosine amidohydrolase-like, PLT | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 27163 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction